Imago Biosciences Inc., of San Francisco, appointed Edgardo Baracchini chief business officer.
Ohana Biosciences, of Cambridge, Mass., appointed Ramiro Castro-Santamaria chief medical officer.
Pharnext SA, of Paris, appointed David Horn Solomon CEO.
Solid Biosciences Inc., of Cambridge, Mass., appointed Ian F. Smith to its board.
Stipe Therapeutics, of Aarhus, Denmark, appointed Natalie Sacks to its board and Richard Bethell chief development officer.
Tearclear Corp., of Boston, appointed Robert J. Dempsey CEO.
Themis Bioscience GmbH, of Vienna, appointed Iain Dukes to its supervisory board.